|
Market Cap (25-Jun) $27,342,400 (1,032nd) |
Close (30-Jun) $0.008 |
Volume (30-Jun) 285,280 |
Shortsold (12-Dec) 6,497 (0.00%) (681st) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.09 |
EX1 released this announcement to the ASX on 20 August 2021, 8:06. The announcement is not marked as price sensitive, and is 20 page(s) in length and 2.77MB in size.
You can view all announcements from EX1 and see how they appear on a price chart on the announcements page.
At the date of this announcement, EX1 was 0.097% short sold according to ASIC data. It was ranked the 454th most shorted stock on the ASX. It remains ranked 681st as of the latest reported data (12 December 2022).
| Other Recent Announcements from EX1 | |
|---|---|
| Initial Director's Interest Notice - MD | 22 June 2023, 11:52 |
| Change of Director's Interest Notice - CB | 22 June 2023, 11:51 |
| Final Director's Interest Notice - JW | 22 June 2023, 11:50 |
| Investor Webinar Presentation | 20 August 2021, 8:06 |
| Notification regarding unquoted securities - EX1 | 2 August 2021, 16:29 |
| Quarterly Activities Report and Appendix 4C | 27 July 2021, 8:22 |
| Update - Partnering & Licensing Focus Continues | 2 July 2021, 8:28 |
You must be logged in to post a reply.
Exopharm 